Steve Kraus

Partner

Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He currently sits on the boards of Bright Health, Welltok, Artemis Health, Groups, Qventus, Remita Health, Docent Health, Alcresta, and is a board observer at Collective Medical Technologies.

Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm as a management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.

He serves as an Observer at Beth Israel Deaconess Medical Center, an advisor to Boston Children’s Hospital and the Harvard Business School’s Center for Entrepreneurship, and on the investment committees of BCBS Massachusetts and Rock Health.

Steve graduated summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.

“Innovating in healthcare is really hard and really rewarding. Make sure you work with people who understand the industry deeply and work in it for all the right reasons."

Companies

Acceleron *

Acceleron

NASDAQ: XLRN

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).

Allena Pharmaceuticals *

Allena Pharmaceuticals

NASDAQ: ALNA

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena Pharmaceuticals went public in November 2017 (NASDAQ: ALNA).

Artemis Health

Artemis Health

Artemis Health’s next-generation data optimization platform enables benefits teams to quantify the impact of their programs, justify new and better programs for their members, and drive their benefits strategy.

ClearCare *

ClearCare

ClearCare is a cloud-based home care software provider. In 2017, ClearCare was acquired.

Collective Medical

Collective Medical

Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care.

DocuTAP *

DocuTAP

ACQUIRED BY: WARBURG PINCUS

DocuTAP provides urgent care EMR and practice management software for healthcare providers. DocuTAP was acquired by Warburg Pincus in 2016.

Flex Pharma, Inc. *

Flex Pharma, Inc.

NASDAQ: FLKS

Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms. In January 2015, Flex Pharma went public (NASDAQ: FLKS).

Groups

Groups

Groups helps people recover from opiate use through therapy and medication.

Insmed *

Insmed

NASDAQ: INSM

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. In 2000, Insmed went public (NASDAQ: INSM).

Kymera Therapeutics

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

Liazon *

Liazon

ACQUIRED BY: TOWERS WATSON & CO.

Liazon is an online benefits store that operates private benefits exchange for businesses. In November 2013, Liazon was acquired by Towers Watson & Co.

Nym

Nym

Nym is a NLU based autonomous medical coding technology that enables healthcare facilities to optimize their revenue cycle processes.

Qventus

Qventus

Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.

Stromedix *

Stromedix

ACQUIRED BY: BIOGEN IDEC.

Stromedix is a biomedical company focused on drugs for fibrosis, organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec.

Subtle Medical

Subtle Medical

Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.

TScan Therapeutics

TScan Therapeutics

TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy

Verastem *

Verastem

NASDAQ: VSTM

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).

Atlas Picks